Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001373894-19-000061)

Filing Details

Accession Number:
0001373894-19-000061
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-14 15:59:32
Reporting Period:
2019-06-12
Accepted Time:
2019-06-14 15:59:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
806517 Psychemedics Corp PMD Services-Medical Laboratories (8071) 581701987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250730 I Michael Schaffer C/O Psychemedics Corporation
289 Great Road, Suite 200
Acton MA 01720		 Vp Of Laboratory Operations No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.005 Par Value Disposition 2019-06-12 2,800 $9.84 25,700 No 4 S Direct
Common Stock, $.005 Par Value Disposition 2019-06-13 2,631 $9.82 23,069 No 4 S Direct
Common Stock, $.005 Par Value Disposition 2019-06-14 3,900 $9.61 19,169 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.63 to $10.00, inclusive. The reporting person undertakes to provide to Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.775 to $9.90, inclusive. The reporting person undertakes to provide to Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.54 to $9.82, inclusive. The reporting person undertakes to provide to Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.